By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioLineRx Ltd. 

19 Hartum Street
P.O. Box 45158
Jerusalem 91450      Israel
Phone: 972-2-548-9100 Fax: 972-2-548-9101


SEARCH JOBS


Industry
Biotechnology






Company News
BioLineRx Ltd. Announces Completion Of Enrollment In CE Mark Registration Trial Of BCM (BL-1040), A Novel Medical Device For Prevention Of Cardiac Remodeling Following Acute Myocardial Infarction 1/14/2015 9:34:49 AM
BioLineRx Ltd. Completes Dose Escalation Stage Of Phase 1 Trial For Novel Stem Cell Mobilization Treatment 1/6/2015 9:15:35 AM
BioLineRx Ltd. To Present At Biotech Showcase 2015 Conference In San Francisco 1/6/2015 8:39:42 AM
BioLineRx Ltd. Out-Licenses Novel Skin Lesion Treatment To Omega Pharma 12/24/2014 9:18:52 AM
BioLineRx Ltd. Presents Multi-Year Clinical Development Plan For Its BL-8040 Hematological Cancer Therapeutic Platform 12/12/2014 9:04:04 AM
BioLineRx Ltd. Reports Positive Data from Ongoing Phase 2a Study for AML Treatment at American Society of Hematology Conference 12/8/2014 10:52:11 AM
BioLineRx Ltd. Reports Third Quarter 2014 Financial Results 11/10/2014 10:12:57 AM
BioLineRx Ltd. Announces Successful Final Results Of Phase 1/2 Study For Novel Celiac Treatment 11/5/2014 9:35:52 AM
BioLineRx Ltd. Files Protocol Amendment To Phase 2 Study For AML Treatment Based On Encouraging Efficacy And Strong Safety Profile 11/3/2014 10:54:36 AM
BioLineRx Ltd. To Report Third Quarter 2014 Results On November 10, 2014 11/3/2014 10:04:30 AM
12345678910...
//-->